Skip to main content

Table 4 Comparison of the changes of parameters before and after treatment between two groups

From: Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients

  Sevelamer
(n = 23)
Calcium Carbonate
(n = 27)
P
Δ Ca (mg/dL) 0.26 ± 0.55 0.80 ± 0.93 0.015*
Δ P (mg/dL) −1.47 ± 0.98 −1.53 ± 1.27 0.871
Δ iPTH (pg/mL) 12.10 (216.60) −137.10 (255.70) 0.026*
Δ ALK-P (IU/L) 30.26 ± 45.78 −2.26 ± 22.69 0.004*
Δ HsCRP (mg/L) −0.9 (2.7) 0.1 (3.8) 0.025*
Δ Hct (%) −0.30 ± 4.00 −0.00 ± 3.39 0.785
Δ Albumin (g/L) 0.00 ± 2.72 0.82 ± 2.31 0.241
Δ TG (mg/dL) −11.00 (70) −13.00 (93) 0.346
Δ LDL-C (mg/dL) −45.04 ± 28.31 −7.74 ± 27.59 0.000*
Δ Fetuin-A (ug/mL) −49.44 (113.78) −38.21 (78.51) 0.345
  1. Δ Ca: the change in serum calcium concentration
  2. Data are mean ± standard deviation or median (interquartile range, IQR)
  3. P < 0.05*